Eliminating a Region of Respiratory Syncytial Virus Attachment Protein Allows Induction of Protective Immunity without Vaccine-enhanced Lung Eosinophilia
Open Access
- 1 June 1998
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 187 (11) , 1921-1926
Abstract
In a murine model of respiratory syncytial virus disease, prior sensitization to the attachment glycoprotein (G) leads to pulmonary eosinophilia and enhanced illness. Three different approaches were taken to dissect the region of G responsible for enhanced disease and protection against challenge. First, mutant viruses, containing frameshifts that altered the COOH terminus of the G protein, were used to challenge mice sensitized by scarification with recombinant vaccinia virus (rVV) expressing wild-type G. Second, cDNA expressing these mutated G proteins were expressed by rVV and used to vaccinate mice before challenge with wild-type respiratory syncytial virus (RSV). These studies identified residues 193–205 to be responsible for G-induced weight loss and lung eosinophilia and showed that this region was not was not necessary for induction of protective immunity. Third, mice were sensitized using an rVV that expressed only amino acids 124–203 of the G protein. Upon RSV challenge, mice sensitized with this rVV developed enhanced weight loss and eosinophilia. This is the first time that a region within RSV (amino acids 193–203) has been shown to be responsible for induction of lung eosinophilia and disease enhancement. Moreover, we now show that it is possible to induce protective immunity with an altered G protein without inducing a pathological response.Keywords
This publication has 34 references indexed in Scilit:
- Respiratory Syncytial Virus Induces Selective Production of the Chemokine RANTES by Upper Airway Epithelial CellsThe Journal of Infectious Diseases, 1997
- Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virusJournal of General Virology, 1996
- Evidence that the amino acid region 124–203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infectionAntiviral Research, 1995
- Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo.Journal of Experimental Medicine, 1995
- Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.Journal of Experimental Medicine, 1995
- Protective And Disease-Enhancing Immune Responses To Respiratory Syncytial VirusThe Journal of Infectious Diseases, 1995
- Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteinsVaccine, 1993
- CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cellsClinical and Experimental Immunology, 1992
- Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.Journal of Clinical Investigation, 1991
- Cytotoxic T Cell Specificity for Respiratory Syncytial Virus Proteins: Fusion Protein Is an Important Target AntigenJournal of General Virology, 1987